Non-fouling Polymer Brush Microarray for Infectious Disease Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infectious disease (ID) testing methods are costly, complex, time-consuming, and require significant infrastructure, with challenges in sensitivity, especially in low-resource settings, due to high background noise from non-specific adsorption and the need for elaborate amplification techniques and microfluidics.
Innovation Solution
A chip with a non-fouling polymer brush that reduces non-specific adsorption, allowing for direct detection from whole blood with femtomolar sensitivity, eliminating the need for preprocessing and microfluidics, and enabling on-site, multiplexed testing using a smartphone for fluorescence imaging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional chemical surface modifications are used on microarrays, then the microarrays can be manufactured with standard techniques, but they exhibit high auto-fluorescence and non-specific binding of reagents and analytes
Solution Approach 1:
The patent changes the chemical parameters of the surface modification by using polyethylene glycol (PEG) chains with specific molecular weights (2,000-20,000 Daltons) and controlled densities (0.1-1.0 chains per nm²). This parameter optimization reduces auto-fluorescence and non-specific binding while maintaining manufacturability through standard microarray fabrication techniques
Solution Approach 2:
The patent creates a composite surface structure by combining PEG chains with the microarray substrate. This composite material approach allows the PEG layer to provide anti-fouling properties while the underlying substrate maintains its functional capabilities for analyte detection
2Productivity
If microarray spot size is reduced to increase density, then more analytes can be detected on a single chip, but non-specific adsorption increases at the pg/cm2 level
Solution Approach 1:
The patent optimizes the PEG layer parameters including chain length (2-20 kDa), density (0.1-1.0 chains/nm²), and thickness (5-50 nm) to achieve optimal performance. These parameter changes enable high-density spot arrangements while maintaining low non-specific adsorption at the pg/cm2 detection level
Solution Approach 2:
The PEG layer acts as an intermediary between the microarray substrate and the analyte solution. It provides a steric barrier that prevents non-specific adsorption of proteins and other biomolecules to the spot surface, while allowing specific analyte-antibody interactions to proceed
3Measurement precision
If elaborate amplification techniques are used to improve sensitivity, then detection limits can be reduced, but the assay becomes more complex and time-consuming
Solution Approach 1:
The patent extracts and eliminates the need for amplification steps by directly detecting analytes bound to the PEG-modified microarray spots. This extraction of unnecessary steps simplifies the assay while maintaining sensitivity through the low-background signal provided by the PEG surface
Solution Approach 2:
The PEG-modified surface provides self-service by inherently reducing non-specific binding without requiring additional blocking agents or complex preparation steps. The surface automatically resists fouling, enabling direct detection
4Reliability
If microfluidics are used for sample processing, then separation and concentration can be achieved, but the device complexity and infrastructure requirements increase
Solution Approach 1:
The patent extracts and removes the microfluidics component entirely from the system. Sample processing is simplified to direct application of diluted sample onto the microarray, eliminating the need for complex microfluidic devices while maintaining adequate separation and detection capabilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides rapid, sensitive, and cost-effective ID testing capable of detecting multiple pathogens from a small blood sample, reducing infrastructure requirements and increasing accessibility, especially in low-resource settings.
Implementation Method 1
A chip with a non-fouling polymer brush that reduces non-specific adsorption
Implementation Method 2
enabling on-site, multiplexed testing using a smartphone for fluorescence imaging
Data Source
AI summary
Disclosed herein are chips, devices, methods of making the same, and methods of detecting a target analyte, and methods of diagnosing an individual with a disease or condition when a target analyte associated with the disease or condition is detected.